zardaverine has been researched along with Bronchial Hyperreactivity in 1 studies
zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.
Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogliani, P | 1 |
| Calzetta, L | 1 |
| Capuani, B | 1 |
| Facciolo, F | 1 |
| Cazzola, M | 1 |
| Lauro, D | 1 |
| Matera, MG | 1 |
1 other study available for zardaverine and Bronchial Hyperreactivity
| Article | Year |
|---|---|
Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness.
Topics: Adenylyl Cyclases; Bronchial Hyperreactivity; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Exen | 2016 |